TP53 and Histone H3.3 Mutations in Triple-Negative Lower-Grade Gliomas.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Annals of nuclear medicine · 2025
   Trial
2. The Oncogenesis of Glial Cells in Diffuse Gliomas and Clinical Opportunities.Neuroscience bulletin · 2023
   Review
3. Epidemiological characteristics and genetic alterations in adult diffuse glioma in East Asian populations.Cancer biology & medicine · 2022
   Review
4. Combinations of Single-Gene Biomarkers Can Precisely Stratify 1,028 Adult Gliomas for Prognostication.Frontiers in oncology · 2022
   Article
5. The dark side of histones: genomic organization and role of oncohistones in cancer.Clinical epigenetics · 2021
   Review
6. A novel image signature-based radiomics method to achieve precise diagnosis and prognostic stratification of gliomas.Laboratory investigation; a journal of technical methods and pathology · 2021
   Article
7. High-resolution melting effectively pre-screens for TP53 mutations before direct sequencing in patients with diffuse glioma.Human cell · 2021
   Article
8. The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET.BMC cancer · 2021
   Article
9. Identification of gene expression and DNA methylation ofPeerJ · 2020
   Article
10. Practice of the New Integrated Molecular Diagnostics in Gliomas: Experiences and New Findings in a Single Chinese Center.Journal of Cancer · 2020
    Article
11. MRI features predict p53 status in lower-grade gliomas via a machine-learning approach.NeuroImage. Clinical · 2018
    Article
12. A prospective study of serum metabolites and glioma risk.Oncotarget · 2017
    Article

Corrections and comments

• Comment on
  Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.2015

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as